Overexpression of TIM-3 on exhausted CD4+ and CD8+ T cells and leukemic cells in patients with chronic lymphocytic leukemia (CML), acute lymphoblastic leukemia (ALL), and CLL, might be a prognostic factor for poor therapeutic response and relapse in patients. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.